Effective with date of service Sept 30, 2022, Medicaid and NC Health Choice cover Indigotindisulfonate sodium injection (Bludigo)
Medicaid Bulletin
Medicaid Bulletin Monthly Digest
Articles beginning January 2018 are available in the blog format.
Indigotindisulfonate Sodium Injection, for Intravenous Use (Bludigo™) HCPCS Code: Billing Guidelines
This error occurred when the LARC was filled by a point-of-sale pharmacy and inserted by the provider in the clinic.
Effective with date of service Oct. 5, 2022, Medicaid and NC Health Choice cover Bevacizumab-maly injection (Alymsys)
Includes HCPCS Code G0512 for RHCs and FQHCs
Taxonomy numbers are not included in Clinical Policy but are included in the associated Fee Schedules.
We encourage stakeholders to provide feedback by Dec. 19, 2022.
The $20 PMPM Medical Home Payments for AMHs serving members eligible for Tailored Care Management will begin in December.
Temporary flexibilities and changes run from Dec. 1, 2022, to March 31, 2023.
NCDHHS will delay the implementation of North Carolina Standard Plan and Tailored Plan Tobacco-Free Policy requirements.
Please post in a prominent location such as patient waiting rooms as soon as possible.